ロード中...
Primary malignant melanoma of uterine cervix treated with pembrolizumab as adjuvant immunotherapy
This is the case report of primary malignant melanoma (MM) of uterine cervix treated by immune checkpoint inhibitor: the Pembrolizumab. Despite the merge of the novel drugs that has been strikingly improving prognosis of MM, we still struggle treatment of MM of uterine cervix that has aggressive cha...
保存先:
| 出版年: | Int Cancer Conf J |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Singapore
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8206436/ https://ncbi.nlm.nih.gov/pubmed/34221842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-021-00477-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|